National Cancer Institute, Slovakia
8 clinical trials · Sponsor
◉ Watch National Cancer Institute, Slovakia
| Record | Firm | Date |
|---|---|---|
| Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer. (NCT07121322) | National Cancer Institute, Slovakia | 2025-07-30 |
| Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation (NCT04691284) | National Cancer Institute, Slovakia | 2021-03-01 |
| Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer. (NCT04265274) | National Cancer Institute, Slovakia | 2020-01-01 |
| Disulfiram and Cisplatin in Refractory TGCTs. (NCT03950830) | National Cancer Institute, Slovakia | 2019-05-14 |
| Avelumab in Refractory Testicular Germ Cell Cancer. (NCT03403777) | National Cancer Institute, Slovakia | 2017-11-15 |
Track National Cancer Institute, Slovakia automatically
Every clearance here is in the API, with alerts when new ones post.